Home Compare MRNA vs SOBI.ST
Stock Comparison · Single-driver result

Moderna vs Swedish Orphan Biovitrum AB (publ): Which Stock Looks Stronger in 2026?

Structurally, Moderna and Swedish Orphan Biovitrum AB (publ) are closely matched — neither holds a meaningful edge overall. Swedish Orphan Biovitrum AB (publ) still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (MRNA: S&P 500, SOBI.ST: STOXX 600).

Updated 2026-06-14

Stability points more clearly toward Swedish Orphan Biovitrum AB (publ), while the broader score stays level overall.

Trajectory Similarity
0.50
Loose match
Peer-set rank: #32
within Moderna, Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This is a looser trajectory match: still usable for comparison, but not especially tight.

The match is driven mainly by investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MRNA
Moderna, Inc.
35
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
SOBI.ST
Swedish Orphan Biovitrum AB (publ)
35
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: MRNA vs SOBI.ST Profitability 17 23 Stability 4 66 Valuation 30 8 Growth 100 61 MRNA SOBI.ST
Gap Ranking
#1 Stability +62
#2 Growth +39
#3 Valuation +22
#4 Profitability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MRNA and SOBI.ST Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MRNASOBI.ST Relative valuation Structural strength

Swedish Orphan Biovitrum AB (publ) still looks cheaper, even though Moderna, Inc. remains structurally stronger.

Valuation position uses peer-relative valuation score and peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
On stability, Swedish Orphan Biovitrum AB (publ) ranks near the top of the group; Moderna, Inc. sits in the weaker half.
Growth
On growth, the edge is clear — both rank well, but Moderna, Inc. sits noticeably higher.
Stability — Dominant Gap
MRNA
4
SOBI.ST
66
Gap+62in favour of SOBI.ST

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Swedish Orphan Biovitrum AB (publ) still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Stability is the clearest driver of the lead, with growth adding further support — though stability still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the MRNA vs SOBI.ST comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how MRNA and SOBI.ST each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.